Madam Speaker, my colleague mentioned both being on the finance committee and also the importance of having a feminist budgetary approach. She would know from finance committee what we have seen repeatedly is people coming before finance committee talking about the importance of having public universal pharmacare in place. Women are disproportionately impacted by the fact that we do not have universal pharmacare in place now. Particularly, with COVID-19, we are seeing more and more women who do not have access to a drug program and cannot pay for their medication. We had the Liberals vote against the Canada Pharmacare Act and we see a complete abandoning of public universal—
In the House of Commons on April 26th, 2021. See this statement in context.